BRITANNIA LIFE SCIENCES Total Liabilities
BRITANNIA LIFE SCIENCES total liabilities. Based on the latest financial reports, BRITANNIA LIFE SCIENCES (L020) has total liabilities worth €4.83 Million EUR (≈ $5.65 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check BRITANNIA LIFE SCIENCES (L020) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of BRITANNIA LIFE SCIENCES (2022–2025)
Total liabilities of BRITANNIA LIFE SCIENCES from 2022 to 2025. This chart illustrates how BRITANNIA LIFE SCIENCES's total liabilities have evolved over time, based on quarterly financial data. Explore L020 long-term investments to assets to see how much of total assets are deployed in long-term investments.
BRITANNIA LIFE SCIENCES Competitors by Total Liabilities
The table below lists competitors of BRITANNIA LIFE SCIENCES ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiankun International Bhd
KLSE:8923
|
Malaysia | RM53.30 Million |
|
Hanwha Corp. Pfd. Series 1
KO:000885
|
Korea | ₩220.39 Trillion |
|
Basel Medical Group Ltd Ordinary Shares
NASDAQ:BMGL
|
USA | $13.60 Million |
|
PT Sunter Lakeside Hotel Tbk
JK:SNLK
|
Indonesia | Rp42.66 Billion |
|
FIRST LITHIUM MINERALS
F:X28
|
Germany | €531.58K |
|
Firebrick Pharma Ltd
AU:FRE
|
Australia | AU$341.73K |
|
Utilico Emerging Markets Ltd
LSE:UEM
|
UK | GBX25.52 Million |
|
E Investment & Development
KO:093230
|
Korea | ₩122.13 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down BRITANNIA LIFE SCIENCES's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BRITANNIA LIFE SCIENCES balance sheet assets.
Liquidity & Leverage Metrics
BRITANNIA LIFE SCIENCES Total Liabilities Ratios Explained
BRITANNIA LIFE SCIENCES total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BRITANNIA LIFE SCIENCES's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BRITANNIA LIFE SCIENCES (2022–2025)
The table below shows the annual total liabilities of BRITANNIA LIFE SCIENCES from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | €5.31 Million ≈ $6.21 Million |
-65.94% |
| 2024-03-31 | €15.59 Million ≈ $18.23 Million |
+24.87% |
| 2023-03-31 | €12.49 Million ≈ $14.60 Million |
-20.00% |
| 2022-03-31 | €15.61 Million ≈ $18.25 Million |
-- |
About BRITANNIA LIFE SCIENCES
Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.